Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Biomedical Development Corporation
Profile last edited on: 10/31/2022      CAGE: 432P3      UEI: CATLLUJNR7W4

Business Identifier: Topical drug delivery system
Year Founded
1983
First Award
1985
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

620 East Dewey Place
San Antonio, TX 78212
   (210) 308-0636
   bdc@biodevcorp.com
   www.biodevcorp.com
Location: Single
Congr. District: 35
County: Bexar

Public Profile

Very early involved in the SBIR arena, Biomedical Development Corporation engages in the research, development, and commercialization of products in the medical and health care fields. With facilities in San Antonio TX and in Lexington KY, the company also develops and manufactures a topical drug delivery system appropriate for dermatology, wound care, and cosmetics.

Extent of SBIR involvement

User Avatar
Phase I Awards
50
Phase II Awards
18
Conversion Rate
36.00%
Phase I Dollars
$5,524,122
Phase II Dollars
$13,332,352
Total Awarded
$18,856,474

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $2,847,021
Project Title: mHealth for Patient Self-Management of Opioid Use Disorder
2016 2 NIH $2,011,630
Project Title: Nonlinear Computation Tool to Chart Trajectories of Bipolar Disorder
2012 2 NIH $1,055,051
Project Title: Unique Anti-Microbial Rinse To Reduce Oral Inflammation
2012 1 NIH $162,266
Project Title: Long-Term Broad-Spectrum Prevention of Implant-Related Infections
2012 1 NIH $199,759
Project Title: Vestibular-Topographical Memory Markers for Those At Risk for Alzheimer's Disease

Key People / Management

  Phyllis B Siegel -- President

  Mary-Ann Bakos

  Bakul M Bhatt

  Charles Lee Bowden

  Barbara Boyan -- Co-Founder

  Norman I Bruckner

  Ginny Donovan

  Kenneth Etzel

  Fred A Gardner

  Charles J Gauntt

  Sharma Jyostsna

  Grazyna Kaminska

  Gemma T Kennedy

  Jack Kessler

  Debra Krieg

  Karl McCloskey -- Senior Research Associate

  W Doss McDavid

  Kenneth C Norbury

  Richard W Osgood

  Larry D Pechacek

  Sophia E Pina

  Jennifer Sharpe Potter

  Fred Previc

  Henry Ralph Rawls

  Greg Siegel

  Larry D Swain

  Barbara Trautner

  Wendy D Warren

  Alfred S Windeler

Company News

There are no news available.